Evidence map›Paper›PMID 36582366›Full record

ArticleFrontiers in public health2022

A roadmap toward implementing health technology assessment in Egypt.

Ahmad Nader Fasseeh, Baher Elezbawy, Mary Gamal, Ahmed Seyam, Asmaa Abourawash, Mohsen George, Mohamed Anwar, Magdy Amin, Ahmed Yehia Khalifa, Amr Elshalakani and 8 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Framework for developing cost-effectiveness analysis threshold: the case of Egypt.The Journal of the Egyptian Public Health Association · 2024
    Article
  8. Maximizing the benefits of using biosimilars in Egypt.Journal of pharmaceutical policy and practice · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ahmad Nader FasseehSyreon Middle East, Alexandria, Egypt.
Baher ElezbawySyreon Middle East, Alexandria, Egypt.
Mary GamalEgyptian Authority for Unified Procurement, Medical Supply and Technology Management, Cairo, Egypt.
Ahmed SeyamUniversal Health Insurance Authority, Cairo, Egypt.
Asmaa AbourawashEgyptian Drug Authority, Cairo, Egypt.
Mohsen GeorgeUniversal Health Insurance Authority, Cairo, Egypt.
Mohamed AnwarDepartment of Data Management and Decision Support, General Authority of Healthcare, Cairo, Egypt.
Magdy AminDepartment of Surgery, Military Medical Academy, Cairo, Egypt.
Ahmed Yehia KhalifaWorld Health Organization Representative Office, Cairo, Egypt.
Amr ElshalakaniHealth, Nutrition and Population Global Practice, World Bank, Cairo, Egypt.
Ashraf HatemFaculty of Medicine, Cairo University, Cairo, Egypt.
Sohir AbdelhamidEgyptian Parliament Health Sector, Cairo, Egypt.
Hossam ElsamoulyPharmaco-Economics Unit, Police Hospitals, Cairo, Egypt.
Nader FasseehFaculty of Medicine, Alexandria University, Alexandria, Egypt.
Randa AdelTakeda Pharmaceuticals, Cairo, Egypt.
Hatem DawoodJanssen Pharmaceutical Companies of Johnson & Johnson, Cairo, Egypt.
Sherif AbazaSyreon Middle East, Cairo, Egypt.
Zoltán KalóCenter for Health Technology Assessment, Semmelweis University, Budapest, Hungary.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: The Egyptian healthcare system is currently in the early phase of health technology assessment (HTA) implementation. The aim of this study is to propose an implementation roadmap based on the national healthcare system status. Methods: A survey was conducted among Egyptian healthcare sector decision-makers to assess the current and future (preferred) HTA implementation status in Egypt based on a widely used international scorecard methodology. Subsequently, interviews were conducted with experts representing middle- and top-tier management in the Egyptian healthcare system to interpret the survey results and recommend specific actions. Results: Experts recommended more capacity-building programs for HTA and health economics. Additionally, they proposed establishing HTA units in separate healthcare authorities and merging them into a single central HTA unit in the long term. Regarding the scope of implementation, experts recommended commencing with the assessment of innovative pharmaceuticals, and thereafter, expanding the scope to cover all health technologies in the long term. Additionally, they recommended using innovative tools such as "multi-criteria decision analysis (MCDA)" for tendering, and "managed entry agreements" for reimbursement decisions. Local burden of diseases and costing studies were also recommended to facilitate the implementation of HTA. Conclusion: Experts agreed that several actions are required for successful HTA implementation in Egypt, including coordination between HTA bodies, application of an explicit MCDA framework, and strengthening of local evidence generation. To implement these actions, investment in technical capacity-building is indispensable. Most experts favored using multiple and soft cost-effectiveness thresholds. Efforts should be made to publish HTA submission guidelines and timelines of the processes.

Indexed as

Capacity BuildingTechnology Assessment, BiomedicalDelivery of Health CareEgyptSurveys and QuestionnairesEgypthealthcare systemhealth policyhealth technology assessmentHTAHTA implementation

Identifiers

PMID36582366
PMCPMC9792961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.